Nalgesin (Naproxen Sodium)

Naproxen sodium works by reversibly blocking the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for the production of prostaglandins. By lowering prostaglandin levels, it reduces inflammation, diminishes pain signals, and helps lower elevated body temperature.

The appropriate dose of Nalgesin is determined by a qualified healthcare professional based on the individual’s condition, age, weight, and response to therapy. Patients should follow the prescriber’s instructions and not alter the dose without medical advice.

Safety of naproxen sodium during pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a healthcare provider.

To order Nalgesin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both Nalgesin (naproxen sodium) and ibuprofen belong to the NSAID class and share similar mechanisms of action. Naproxen generally has a longer half‑life, allowing less frequent dosing, while ibuprofen may have a quicker onset. Choice between them depends on clinical response, dosing convenience, and individual safety considerations.

Nalgesin should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture and direct sunlight to maintain its stability throughout its shelf life.

Nalgesin is administered orally, typically as a tablet swallowed with a full glass of water. It may be taken with food or milk to lessen gastrointestinal irritation, but patients should follow the specific instructions provided by their prescriber.

The most serious risks include gastrointestinal bleeding or ulcer perforation, cardiovascular events such as heart attack or stroke, severe renal impairment, and rare but life‑threatening skin reactions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they notice signs of these conditions.

Nalgesin should be avoided in individuals with known hypersensitivity to naproxen or other NSAIDs, active gastrointestinal ulcer disease, severe heart failure, uncontrolled hypertension, or significant renal or hepatic impairment unless specifically directed by a physician.